Pill Identifier App

Clinical Trials Update: April 21, 2008

-- Here are the latest clinical trials, courtesy of Thomson CenterWatch:


This clinical trial will evaluate a study drug in people with atherosclerotic disease. To qualify, you must be at least 18 and have a history of atherosclerosis involving the coronary, cerebral, or peripheral vascular systems.

The research site is in New Hyde Park, N.Y.

More information

Please see http://www.centerwatch.com/patient/studies/cat17.html.


Solid Tumors

This is a phase-2 study designed to evaluate the safety and effectiveness of NKTR-102 (PEG-irinotecan) to treat colorectal cancer.

The research site is in Dallas, Texas.

More information

Please see http://www.centerwatch.com/patient/studies/cat424.html.



This study will evaluate lacosamide monotherapy in people with partial-onset seizures who have stopped using one or two marketed antiepileptic drugs. Candidates must be diagnosed with epilepsy with simple partial seizures (motor component) and/or complex partial seizures, and must be experiencing two to 40 seizures per 28-day period.

The research site is in Edison, NJ.

More information

Please see http://www.centerwatch.com/patient/studies/cat62.html.


Copyright 2008 CenterWatch. All rights reserved.

Posted: April 2008

View comments